Travel vaccines market size grows by $2.44 billion with 42% contribution from North America – Technavio

NEW YORK, August 22, 2022 /PRNewswire/ — The latest market analysis report titled Travel Vaccines Market by Disease Type and Geography – Forecast and Analysis 2022-2026 was recently added to Technavio’s catalog. Report analysts have categorized the global travel vaccines market as part of the global pharmaceuticals market. Our report provides detailed insights on value chain analysis for Travel Vaccines Market which vendors can leverage to gain a competitive edge during the forecast period. The data available in our value chain analytics segment can help vendors reduce costs and improve customer services over the forecast period. Rising global travel and migration is one of the major drivers for the growth of the global travel vaccines market. Additionally, changes in the demographics of travelers globally are one of the key travel vaccine market trends that are expected to positively impact the industry during the forecast period. However, the lack of coverage for travel vaccines in many health plans is expected to limit the market growth over the forecast period.

The latest market research report titled Travel Vaccines Market by Disease Type and Geography – Forecast and Analysis 2022-2026 has been announced by Technavio, which has been proud to partner with Fortune 500 companies for over 16 years

For market scope, value chain analysis, and key market dynamics, Read a FREE sample

Travel Vaccines Market Segmentation Highlights

For more industry information and regional opportunities, Sample Report Request

  • The travel vaccines market is fragmented and vendors are deploying growth strategies such as R&D investment to compete in the market. The Travel Vaccines Market forecast report offers in-depth information about key vendor profiles. The profiles include production, sustainability and outlook information for key companies.

  • Abbott Laboratories, Altimmune Inc., AstraZeneca Plc, Bharat Biotech Ltd., CSL Ltd., Dynavax Technologies Corp., Emergent BioSolutions Inc., GlaxoSmithKline Plc, KM Biologics Co. Ltd., LG Chem Ltd., Merck and Co. Inc. , Mitsubishi Chemical Holdings Corp., Pfizer Inc., Sanofi, Serum Institute of India Pvt. Ltd., Shenzhen Kangtai Biological Products Co. Ltd., Sinovac Biotech Ltd., SK Chemicals Co. Ltd., Takeda Pharmaceutical Co. Ltd. and Valneva SE are among the major players in the market.

  • To make the most of the opportunities, sellers in the market should focus more on growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

  • Vendors offer a wide range of offerings to gain a competitive advantage in the market. For example, CSL Ltd. offers the broadest influenza vaccine and a wide range of vaccines and specialty medicines that meet unique local public health needs. Bharat Biotech Ltd. offers travel vaccines such as BioHib, a freeze-dried vaccine used for development based on an Indian strain.

  • Backed by competitive intelligence and benchmarking, our travel vaccines market research reports are designed to provide entry assistance, customer profiling and M&A as well as go-to-market strategy support on the market.

Other supplier offerings and their strategic initiatives are available in this Sample PDF report

Travel Vaccines Market Scope

Technavio presents a detailed picture of the market through study, synthesis and summation of data from multiple sources. Our travel vaccines market report covers the following areas:

Travel Vaccines Market Highlights

  • Market CAGR over the forecast period 2022-2026

  • In-depth information on factors that will contribute to the growth of the Travel Vaccines Market over the next five years

  • Estimation of the travel vaccines market size and its contribution to the parent market

  • Predictions on upcoming trends and changes in consumer behavior

  • The growth of the travel vaccine market

  • Market Competitive Landscape Analysis and Detailed Vendor Information

  • Comprehensive details of factors that will challenge the growth of the Travel Vaccines Market vendors

Related reports:

Vaccine market by Type and Geography – Forecast and Analysis 2022-2026

Human Combination Vaccines Market by Type and Geography – Forecast and Analysis 2021-2025

Therapeutic Vaccines Market by Type and Geography – Forecast and Analysis 2020-2024

Foot and Mouth Disease Vaccines Market by Product and Geography – Forecast and Analysis 2021-2025

Travel Vaccines Market Scope

Report cover

Details

Page number

120

base year

2021

Forecast period

2022-2026

Growth momentum and CAGR

Accelerate at a CAGR of 8.59%

Market Growth 2022-2026

$2.44 billion

Market structure

Fragmented

Annual growth (%)

7.85

Regional analysis

North America, Europe, Asia and Rest of the World (ROW)

Successful market contribution

North America at 42%

Main consumer countries

United States, Germany, United Kingdom, Japan and China

Competitive landscape

Leading companies, competitive strategies, scope of consumer engagement

Profiled companies

Abbott Laboratories, Altimmune Inc., AstraZeneca Plc, Bharat Biotech Ltd., CSL Ltd., Dynavax Technologies Corp., Emergent BioSolutions Inc., GlaxoSmithKline Plc, KM Biologics Co. Ltd., LG Chem Ltd., Merck and Co. Inc. , Mitsubishi Chemical Holdings Corp., Pfizer Inc., Sanofi, Serum Institute of India Pvt. Ltd., Shenzhen Kangtai Biological Products Co. Ltd., Sinovac Biotech Ltd., SK Chemicals Co. Ltd., Takeda Pharmaceutical Co. Ltd. and Valneva SE

Market dynamics

Parent market analysis, market growth drivers and barriers, analysis of fast growing and slow growing segments, impact of COVID 19 and future consumer dynamics, and analysis of market conditions for the forecast period.

Personalization area

If our report does not include the data you are looking for, you can contact our analysts and customize the segments.

Contents :

1. Summary

2 Market landscape

3 Market sizing

4 Five forces analysis

5 Market Segmentation by Disease Type

6 Customer Landscape

7 Geographic landscape

8 drivers, challenges and trends

9 Supplier landscape

10 Vendor Analysis

11 Appendix

About Us

Technavio is a global leader in technology research and consulting. Their research and analysis focuses on emerging market trends and provides actionable insights to help companies identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialist analysts, Technavio’s reporting library consists of over 17,000 reports and counts, spanning 800 technologies, spanning 50 countries. Their customer base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing customer base relies on Technavio’s comprehensive coverage, in-depth research, and actionable market intelligence to identify opportunities in existing markets and potentials and assess their competitive positions in changing market scenarios.

Contact

Technavio Research
Jesse Maida
Media & Marketing Manager
USA: +1 844 364 1100
UK: +44 203 893 3200
E-mail: media@technavio.com
Website: www.technavio.com/

Technavio (PRNewsfoto/Technavio)

Technavio (PRNewsfoto/Technavio)

Quote

Quote

See original content to download multimedia: https://www.prnewswire.com/news-releases/usd-2-44-billion-growth-in-travel-vaccines-market-size-with-42-of-the -contribution-from-north-america—technavio-301609618.html

SOURCETechnavio

#Travel #vaccines #market #size #grows #billion #contribution #North #America #Technavio

Add Comment